Pharma & life sciences | Modelled case study
Keep clinical-trial signatures verifiable through the study lifecycle
Will consent, source-data, analysis, and submission signatures remain attributable and verifiable years after systems change?
The modelled organisation
A recognisable problem reaches the operating agenda
This composite scenario follows the Clinical Systems · Quality Assurance · Biostatistics functions. It is grounded in the cited problem context but does not identify a real customer.
Operating environment
A life-sciences organisation moves regulated and commercially sensitive data through instruments, laboratories, research partners, trial platforms, archives, and submissions.
What is at stake
Loss of provenance or long-term confidentiality can undermine a study, expose valuable research, delay a submission, or make a regulated record indefensible.
Situation
Long-running trials cross vendors, countries, and platform migrations, while signature evidence can become inseparable from retired identity and timestamp services.
Event that forces action
A decentralized trial, e-signature platform replacement, or long-term archive design.
Concrete system boundary
Systems this case study puts in scope
The model is specific about the operational surfaces that must be discovered, changed, or independently checked.
site data capture
trial master file
signature and timestamp validation
long-term study archive
Modelled case study walkthrough
How this organisation would use QNSI
The walkthrough connects the real-world problem to a bounded QNSI contribution and an independently reviewable result.
Recognise the operating condition
Long-running trials cross vendors, countries, and platform migrations, while signature evidence can become inseparable from retired identity and timestamp services.
Frame the decision the owners must make
Will consent, source-data, analysis, and submission signatures remain attributable and verifiable years after systems change?
Apply QNSI to the controlled boundary
Inventory signature algorithms, signer identities, certificate chains, timestamps, and archive dependencies in QNSI.
Leave the team with a concrete result
A trial-signature longevity register with revalidation checkpoints and evidence-preservation actions.
Prove the result in the organisation's environment
Quality and regulatory teams confirm electronic-record requirements, identity proofing, timestamp trust, retention, and admissibility.
What useful success looks like
A decision artifact plus proof from the real environment
The model stops at a target result. It becomes an actual case study only when a customer produces and independently validates this evidence in production.
Decision artifact
A trial-signature longevity register with revalidation checkpoints and evidence-preservation actions.
Independent validation boundary
Quality and regulatory teams confirm electronic-record requirements, identity proofing, timestamp trust, retention, and admissibility.
Real-world problem grounding
Primary sources behind the model
These sources establish the external requirement, failure mode, or risk context used to model this case. They do not endorse HEOSSI or prove that QNSI completed the scenario.
Customer evidence status
This is modelled, not a customer claim
The organisation is a composite and the result is a target state. This page does not prove a deployment, customer outcome, certification, legal conclusion, regulator endorsement, or completed control.